Market Forecast News: Oxygen Concentrators Industry to Hit $1.71B by 2030
The report "Oxygen Concentrators Market by Type (Portable, Stationary), Technology (Continuous and Pulse Flow), Flowrate (0-5L/Min, 5-10L/Min, Above 10L/Min), Application (Chronic Obstructive Pulmonary Disorder), End User (Home Care Settings) - Global Forecast to 2030", is projected to reach USD 1.71 billion by 2030 from USD 1.27 billion in 2025, at a CAGR of 6.1% during the forecast period.
Browse 237 market data Tables and 57 Figures spread through 245 Pages and in-depth TOC on "Oxygen Concentrators Market - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/oxygen-concentrator-market-199087330.html
The increasing popularity of home healthcare significantly boosts the demand for oxygen concentrators. Patients with chronic respiratory conditions often need long-term oxygen therapy, which can be managed effectively at home with compact, portable oxygen concentrators. This trend is driven by the desire to reduce hospital visits, prevent prolonged stays, lower treatment costs, and improve patient comfort. The COVID-19 pandemic notably accelerated this shift, as hospitals faced capacity issues and patients sought safer treatment options outside clinical settings. The oxygen concentrators market is expected to continue benefiting from this growing and sustained demand.
Portable oxygen concentrators will hold the highest share, by product, in the oxygen concentrators market.
Based on type, the market for OC is divided into portable oxygen concentrators and stationary oxygen concentrators. In 2024, the portable oxygen concentrator segment holds the largest share of the global oxygen concentrators market. The portable oxygen concentrators (POC) segment is expected to dominate the market due to increasing demand for mobility-friendly and user-focused oxygen therapy solutions. Patients with chronic respiratory conditions such as COPD, pulmonary fibrosis, and other long-term lung diseases need consistent oxygen delivery, even when away from home. POCs provide convenience, freedom of movement, and the ability to travel, which is especially valued by the elderly and active adults. Unlike bulky stationary units, POCs are small, battery-powered, and often FAA-approved for air travel. The global aging population and rising diagnosis of respiratory diseases are further boosting demand. Additionally, technological innovations have made these devices lighter, quieter, and more energy-efficient.
The home care settings segment held the highest revenue share of the oxygen concentrators market in 2024.
Based on end users, the OC market has been divided into home care settings, hospitals and clinics, ambulatory surgical centers, and physician offices. In 2024, home care settings held the largest share of the OC market. Managing oxygen therapy at home is much more cost-effective than extended hospital stays, especially in countries with high hospitalization costs. Patients with chronic respiratory conditions such as COPD or sleep apnea increasingly prefer the comfort and familiarity of home, which boosts treatment adherence and quality of life. Additionally, home-based oxygen therapy helps lower hospital overcrowding and reduces the risk of hospital-acquired infections. With the growth of digital health tools and telemedicine, remote patient monitoring has become easier and more efficient. Insurance coverage and reimbursement policies have also supported home-based treatment options. Governments and healthcare providers are encouraging home care to lessen the burden on healthcare systems, while manufacturers are developing compact, user-friendly devices for home use. These factors together have driven home care to the forefront of the oxygen concentrators market.
In 2024, North America accounted for the largest share of the oxygen concentrators market.
North America became the top region in the oxygen concentrators market, driven by high disease rates, supportive reimbursement policies, and a strong home healthcare system. The region has seen a significant cultural and structural shift toward home-based medical care, especially for chronic conditions like COPD and obstructive sleep apnea. Rising healthcare costs, limited hospital capacity, and patient preference for comfort at home have sped up this change. The U.S. leads in adoption because of its advanced healthcare system and early adoption of portable oxygen concentrator technology. Regulatory support, such as FDA approvals, and comprehensive insurance coverage, have further fueled growth. Moreover, North America has experienced quick progress in telehealth and remote patient monitoring, which supports the use of home oxygen devices. Public awareness campaigns, a strong presence of manufacturers, and ongoing innovation in device portability and efficiency also play vital roles. These factors make North America the leading region in this growing market.
The leading companies in the oxygen concentrators market include Koninklijke Philips N.V. (Netherlands), Inogen, Inc. (US), Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (China), TEIJIN LIMITED (Japan), DAIKIN INDUSTRIES, Ltd. (Japan), ESAB Corporation (GCE GROUP) (Switzerland), Caire, Inc. (US), React Health (Dublin), Precision Medical Inc. (US), Drive DeVilbiss Healthcare (US), and Nidek Medical Products, Inc. (US), among others. These companies have used various growth strategies, such as launching new products, acquisitions, and expansion efforts, to strengthen their presence and reach in the oxygen concentrators market.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Oxygen Concentrators Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
